Effects of an Angiotensin II Antagonist on Ischemic and Nonischemic Isolated Rat Hearts
Yosef Paz(Tel Aviv Sourasky Medical Center), Gad Keren(Assuta Medical Center), Inna Frolkis(Tel Aviv University), Chaim Locker(Tel Aviv Sourasky Medical Center), Menachem Matsa(Tel Aviv Sourasky Medical Center), Jacob Gurevitch(Tel Aviv University), Amir Kramer(Tel Aviv Sourasky Medical Center), Rephael Mohr(Charité - Universitätsmedizin Berlin)
Cited by 29
Related Papers
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347